• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 HIV 中和抗体广谱性相关的异常 B 细胞库选择。

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth.

机构信息

Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH, USA.

Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

Nat Immunol. 2020 Feb;21(2):199-209. doi: 10.1038/s41590-019-0581-0. Epub 2020 Jan 20.

DOI:10.1038/s41590-019-0581-0
PMID:31959979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7223457/
Abstract

A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth.

摘要

HIV 疫苗研发的目标是诱导具有中和广度的抗体。HIV 的广谱中和抗体(bnAbs)通常具有不寻常的序列,其重链互补决定区环较长、体细胞突变率高且具有多反应性。HIV 感染个体的一部分会产生此类抗体,但尚不清楚这是否反映了其抗体库的系统性差异,还是涉及单个克隆的罕见随机事件的结果。我们对具有 bnAb 反应或无中和广度的 HIV 感染者以及未感染者的大样本队列中的抗体重链库进行了测序,确定了 bnAb 库的一致特征,每个个体包含数千个 B 细胞克隆,并伴有相关的 T 细胞表型。在另一项独立队列的慢性巨细胞病毒感染中未观察到这些库特征。我们的数据表明,具有与自身反应性相关的抗体特征的大量 B 细胞谱系的发展可能是 HIV 中和抗体广度发展的关键方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/e369660404b0/41590_2019_581_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/f5a6a5c2ede9/41590_2019_581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/10d8593916e7/41590_2019_581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/5e172fb285bd/41590_2019_581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/56db5343d82a/41590_2019_581_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/c36841bdde9a/41590_2019_581_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/dec8e45219d0/41590_2019_581_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/e369660404b0/41590_2019_581_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/f5a6a5c2ede9/41590_2019_581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/10d8593916e7/41590_2019_581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/5e172fb285bd/41590_2019_581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/56db5343d82a/41590_2019_581_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/c36841bdde9a/41590_2019_581_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/dec8e45219d0/41590_2019_581_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bb/7223457/e369660404b0/41590_2019_581_Fig7_HTML.jpg

相似文献

1
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth.与 HIV 中和抗体广谱性相关的异常 B 细胞库选择。
Nat Immunol. 2020 Feb;21(2):199-209. doi: 10.1038/s41590-019-0581-0. Epub 2020 Jan 20.
2
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.抗体重链和轻链体细胞超突变在赋予 HIV-1 特异性 CAP256-VRC26 bNAb 谱系广度和效力方面的互补作用。
J Virol. 2022 May 25;96(10):e0027022. doi: 10.1128/jvi.00270-22. Epub 2022 May 5.
3
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth.HIV 中和抗体广谱应答控制者体内 B 细胞的独特克隆进化。
Elife. 2021 Apr 12;10:e62648. doi: 10.7554/eLife.62648.
4
Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.HIV-1 bNAbs 的多反应性和自身反应性:对疫苗设计的影响。
Retrovirology. 2018 Jul 28;15(1):53. doi: 10.1186/s12977-018-0435-0.
5
Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.在非人灵长类动物中疫苗引发罕见的 HIV 广谱中和抗体前体。
Science. 2024 May 17;384(6697):eadj8321. doi: 10.1126/science.adj8321.
6
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.基于突变的疫苗设计:一种开发 HIV 广谱中和抗体诱导增强免疫原的方法。
Cell Host Microbe. 2024 May 8;32(5):693-709.e7. doi: 10.1016/j.chom.2024.04.006. Epub 2024 Apr 25.
7
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.用于诱导V2靶向HIV广泛中和抗体的基于个体发生的免疫原。
Immunol Rev. 2017 Jan;275(1):217-229. doi: 10.1111/imr.12501.
8
Vaccination induces broadly neutralizing antibody precursors to HIV gp41.接种疫苗可诱导针对 HIV gp41 的广谱中和抗体前体。
Nat Immunol. 2024 Jun;25(6):1073-1082. doi: 10.1038/s41590-024-01833-w. Epub 2024 May 30.
9
Lessons learned from human HIV vaccine trials.从人类HIV疫苗试验中吸取的教训。
Curr Opin HIV AIDS. 2017 May;12(3):216-221. doi: 10.1097/COH.0000000000000362.
10
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.HIV-1疫苗。使用靶向种系的免疫原引发对HIV-1的广泛中和抗体反应。
Science. 2015 Jul 10;349(6244):156-61. doi: 10.1126/science.aac5894. Epub 2015 Jun 18.

引用本文的文献

1
Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution.HTLV-2 合并感染个体中增强的 HIV-1 中和抗体广度:抗逆转录病毒治疗方案和 B 细胞亚群分布的影响
Vaccines (Basel). 2025 Jun 13;13(6):639. doi: 10.3390/vaccines13060639.
2
Disease diagnostics using machine learning of B cell and T cell receptor sequences.利用B细胞和T细胞受体序列的机器学习进行疾病诊断
Science. 2025 Feb 21;387(6736):eadp2407. doi: 10.1126/science.adp2407.
3
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth.

本文引用的文献

1
Presence and significance of cold agglutinins in patients with HIV infection.HIV感染患者中冷凝集素的存在及其意义。
Haematologica. 1992 May-Jun;77(3):233-6.
急性HIV-1感染中表达CD16和CD57的γδT细胞与中和广度的发展相关。
PLoS Pathog. 2025 Jan 31;21(1):e1012916. doi: 10.1371/journal.ppat.1012916. eCollection 2025 Jan.
4
Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques.恒河猴感染猴免疫缺陷病毒(SHIV)后诱导产生的针对 HIV-1 的中和抗体与新生儿免疫相关。
Nat Commun. 2024 Nov 27;15(1):10302. doi: 10.1038/s41467-024-54753-6.
5
The role of polyreactive memory B cells in systemic lupus erythematosus.多反应性记忆B细胞在系统性红斑狼疮中的作用。
Int Immunol. 2025 Mar 6;37(4):189-194. doi: 10.1093/intimm/dxae058.
6
Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to pneumococcal vaccination.全长单细胞 BCR 测序与 RNA 测序相结合揭示了对肺炎球菌疫苗接种的趋同反应。
Commun Biol. 2024 Sep 28;7(1):1208. doi: 10.1038/s42003-024-06823-0.
7
Robust detection of infectious disease, autoimmunity, and cancer from the paratope networks of adaptive immune receptors.从适应性免疫受体的互补决定区网络中稳健地检测传染病、自身免疫和癌症。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae431.
8
Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention.中和威胁:利用抗HIV-1的广谱中和抗体进行治疗和预防。
Microb Cell. 2024 Jul 3;11:207-220. doi: 10.15698/mic2024.07.826. eCollection 2024.
9
RAIN: machine learning-based identification for HIV-1 bNAbs.基于机器学习的 HIV-1 广谱中和抗体鉴定
Nat Commun. 2024 Jun 24;15(1):5339. doi: 10.1038/s41467-024-49676-1.
10
RAIN: a Machine Learning-based identification for HIV-1 bNAbs.RAIN:一种基于机器学习的HIV-1广谱中和抗体识别方法。
Res Sq. 2024 Mar 8:rs.3.rs-4023897. doi: 10.21203/rs.3.rs-4023897/v1.